2024 SCHEDULE

THURSDAY, APRIL 18 - PHARMACOLOGY PRECONFERENCE AND GENERAL SESSIONS
7:30 AM ETBreakfast served.
8:00 AM ETProduct Theater hosted by Pfizer
Recognizing Attr-Cm in Your HFpEF Patients: A Case-Based Approach for Cardiovascular Nurses
8:45 AM ETWelcome to Pharmacology Preconference
9:00 AM ETHypertension: Responsive versus Resistant
Cheryl Dennison Himmelfarb, PhD, RN, FAAN, FAHA, FPCNA
9:50 AM ETActivity Break
10:00 AM ETCognition and CVD: The Brain and the Heart
Brittany Butts, PhD, RN
10:50 AM ETHold What?! Cardiac Clearance for Cardiovascular Procedures
Jane Linderbaum, ARNP, CNP
11:40 PM ETLunch served
12:00 PM ETProduct Theater hosted by Regeneron
Time Is Plaque: Identifying and Diagnosing Homozygous Familial Hypocholesteremia (HoFH) Early To Reduce Risk of Premature Cardiovascular Event and Mortality
12:45 PM ETWeight Loss: Pharmacological Interventions Round Table
Lisa Maher, DNP, ARNP, FNP-BC, FPCNA
Chiadi Ndumele, MD, PhD
Cindy Lamendola, MSN, NP
Sheila Allen, Patient Champion
1:35 PM ETAnnouncements
1:40 PM ETExhibit Hall Open and Beverage Break
2:40 PM ETWelcome to General Sessions
3:00 PM ETDiversity, Health Equity and Inclusion: National and Global Perspectives on CVD
Clyde Yancy, MD, MSc, MACC, MACP, FAHA, FHFSA, FRCP, FASPC (Hon.), FPCNA (Hon.)
3:50 PM ETSpotlight on HFpEF: Heart Failure Guidelines
Chiadi Ndumele, MD, PhD
4:35 PM ETAwards Ceremony
5:15 PM ETWelcome from Florida PCNA Chapters
5:30 PM ETOpening Reception in the Exhibit Hall with Poster Presentations
6:30 PM ETDinner & CE:
Forecasting Patient Access and Innovation
Sponsored by the American Society for Preventive Cardiology in conjunction with
Partnership to Advance Cardiovascular Health
FRIDAY, APRIL 19 - GENERAL SESSIONS
7:30 AM ETBreakfast served
8:00 AM ETProduct Theater hosted by Novo Nordisk
More Than Just Weight Loss: Discover the Power of a GLP-1 RA
8:45 AM ETWelcome
Poster Winners Announced
9:00 AM ETSleep: An Overdue Addition to Life's Essential 8
Virend Somers, MD, PhD
9:45 AM ETManagement of Chronic Coronary Disease: 2023 Guidelines
Kristin Newby, MD, MHS, FACC, FAHA, FESC
10:30 AM ETActivity Break
10:40 AM ETArtificial Intelligence: Leveraging AI for CVD Management
Osama Dasa, MD, MPH, PhD
Eileen Handberg ​PhD, ANP-BC, FACC
Yvonne Commodore-Mensah PhD, MHS, RN, FAAN, FAHA, FPCNA
Heidi Salisbury RN, MSN, CNS-BC, ACGN
11:25 AM ETTransitions of Care (ToC) for the CVD Patient
Bailey DeBlasis, MPH, MSW, LISW-S
Emily Jones PhD, RNC-OB, FAHA, FPCNA
12:10 PM ETOral Abstract Presentations
12:45 PM ETLunch served
1:00 PM ETNon CE Disease State Theater Hosted by Johnson and Johnson Innovative Medicine
Health Disparities in Atrial Fibrillation
1:45 PM ETExhibit Hall
2:50 PMTransition to Breakout Rooms
3:00 PM ETBreak Out Sessions (pick one)
Workplace Violence: Techniques for defusing hostile scenarios
Mark Kincaid, BAEM, CHSS, CPI/NCII
Murmurs: What's the Whoosh?
Christian Lorenzo, MD
Remote Patient Monitoring in Heart Failure and Beyond
Kim Newlin, RN, CNS, ANP-C
3:50 PM ETTransition to Breakout Rooms
4:00 PM ETBreak Out Sessions (pick one)
Workplace Violence: Techniques for defusing hostile scenarios
Mark Kincaid, BAEM, CHSS, CPI/NCII
Murmurs: What's the Whoosh?
Christian Lorenzo, MD
Remote Patient Monitoring in Heart Failure and Beyond
Kim Newlin, RN, CNS, ANP-C
5:00 PM ETHypertriglyceridemia Treatment: Reducing ASCVD Risk for Secondary Prevention
CE Session supported by Amarin
SATURDAY, APRIL 20 - GENERAL SESSIONS
7:30 AM ETBreakfast
8:00 AM ETProduct Theater hosted by Bristol Myers Squibb
A Case-Based Discussion on Cardiac Myosin Inhibition in the Management of Patients With Nyha Class II–III Obstructive HCM
8:45 AM ETWelcome
8:50 AM ETPrevention as Early Intervention
Martha Gulati, MD, MS, FACC, FAHA, FASPC, FESC, FSCCT
9:35 AM ETActivity Break
9:55 AM ETWomen's CVD and Hormonal Transitions Across the Lifespan
Priya Vellanki, MD, MS
10:40 AM ETPresidential Transition
10:50 AM ETAdvocacy in Nursing
Elizabeth Aquino, PhD, RN
11:50 AM ETClosing and Prize Drawing
12:00 PM ETMeeting Adjourns

For more information on each program topic, see the Learning Objectives.

ACCREDITATION STATEMENT

This educational activity is provided by the Preventive Cardiovascular Nurses Association (PCNA). Multiple educational grants have been requested to support this program. PCNA is approved as a provider of nurse practitioner continuing education (CE) programs by the American Association of Nurse Practitioners (AANP), provider number 030602. This program was planned in accordance with AANP CE Policies and Commercial Support Standards.